Follow-up Guidelines, Evidence, and Recommendations

Merel Kimman; Marjan van Hezewijk; Liesbeth J. Boersma

doi:10.1007/978-3-030-91170-6_30

Follow-up Guidelines, Evidence, and Recommendations

Merel Kimman^*, Marjan van Hezewijk, Liesbeth J. Boersma

^*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic

Abstract

The current section aims to revisit current clinical practice guidelines for follow-up, summarize the evidence for strategies, highlight benefits of a more personalized approach to follow-up care, and provide recommendations. In most countries, guidelines prescribe follow-up visits after primary treatment every 3–4 months in the first 2–3 years, every 6–12 months from years 3 to 5, and annually thereafter. The exact frequency, duration, and intensity differ per country and even hospital. High-level evidence for any particular follow-up strategy is lacking and here lies an opportunity for health professionals to take into account a patient’s risk of recurrence, quality of life needs, and preferences. Decision aids and patient-reported outcome measures can play a supporting role in providing more personalized follow-up care.

Original language	English
Title of host publication	Breast Cancer Radiation Therapy
Subtitle of host publication	A Practical Guide for Technical Applications
Editors	Orit Kaidar-Person, Icro Meattini, Philip Poortmans
Publisher	Springer International Publishing
Pages	221-224
Number of pages	4
ISBN (Electronic)	9783030911706
ISBN (Print)	9783030911690
DOIs	https://doi.org/10.1007/978-3-030-91170-6_30
Publication status	Published - 1 Jan 2022

Access to Document

10.1007/978-3-030-91170-6_30

Cite this

@inbook{d0803a87698048dabf0454092f7f8e00,

title = "Follow-up Guidelines, Evidence, and Recommendations",

abstract = "The current section aims to revisit current clinical practice guidelines for follow-up, summarize the evidence for strategies, highlight benefits of a more personalized approach to follow-up care, and provide recommendations. In most countries, guidelines prescribe follow-up visits after primary treatment every 3–4 months in the first 2–3 years, every 6–12 months from years 3 to 5, and annually thereafter. The exact frequency, duration, and intensity differ per country and even hospital. High-level evidence for any particular follow-up strategy is lacking and here lies an opportunity for health professionals to take into account a patient{\textquoteright}s risk of recurrence, quality of life needs, and preferences. Decision aids and patient-reported outcome measures can play a supporting role in providing more personalized follow-up care.",

author = "Merel Kimman and Hezewijk, {Marjan van} and Boersma, {Liesbeth J.}",

year = "2022",

month = jan,

day = "1",

doi = "10.1007/978-3-030-91170-6_30",

language = "English",

isbn = "9783030911690",

pages = "221--224",

editor = "Orit Kaidar-Person and Meattini, {Icro } and Poortmans, {Philip }",

booktitle = "Breast Cancer Radiation Therapy",

publisher = "Springer International Publishing",

address = "Switzerland",

}

Follow-up Guidelines, Evidence, and Recommendations. / Kimman, Merel; Hezewijk, Marjan van; Boersma, Liesbeth J.
Breast Cancer Radiation Therapy: A Practical Guide for Technical Applications. ed. / Orit Kaidar-Person; Icro Meattini; Philip Poortmans. Springer International Publishing, 2022. p. 221-224.

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic

TY - CHAP

T1 - Follow-up Guidelines, Evidence, and Recommendations

AU - Kimman, Merel

AU - Hezewijk, Marjan van

AU - Boersma, Liesbeth J.

PY - 2022/1/1

Y1 - 2022/1/1

N2 - The current section aims to revisit current clinical practice guidelines for follow-up, summarize the evidence for strategies, highlight benefits of a more personalized approach to follow-up care, and provide recommendations. In most countries, guidelines prescribe follow-up visits after primary treatment every 3–4 months in the first 2–3 years, every 6–12 months from years 3 to 5, and annually thereafter. The exact frequency, duration, and intensity differ per country and even hospital. High-level evidence for any particular follow-up strategy is lacking and here lies an opportunity for health professionals to take into account a patient’s risk of recurrence, quality of life needs, and preferences. Decision aids and patient-reported outcome measures can play a supporting role in providing more personalized follow-up care.

AB - The current section aims to revisit current clinical practice guidelines for follow-up, summarize the evidence for strategies, highlight benefits of a more personalized approach to follow-up care, and provide recommendations. In most countries, guidelines prescribe follow-up visits after primary treatment every 3–4 months in the first 2–3 years, every 6–12 months from years 3 to 5, and annually thereafter. The exact frequency, duration, and intensity differ per country and even hospital. High-level evidence for any particular follow-up strategy is lacking and here lies an opportunity for health professionals to take into account a patient’s risk of recurrence, quality of life needs, and preferences. Decision aids and patient-reported outcome measures can play a supporting role in providing more personalized follow-up care.

U2 - 10.1007/978-3-030-91170-6_30

DO - 10.1007/978-3-030-91170-6_30

M3 - Chapter

SN - 9783030911690

SP - 221

EP - 224

BT - Breast Cancer Radiation Therapy

A2 - Kaidar-Person, Orit

A2 - Meattini, Icro

A2 - Poortmans, Philip

PB - Springer International Publishing

ER -

Follow-up Guidelines, Evidence, and Recommendations

Abstract

Access to Document

Fingerprint

Cite this